FindTrial
Sign In

A study to compare various medicines to be used for ascending rapidly on mountains

A study on rapid induction via Manali-Leh Road: A randomised field trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/11/010502
Enrollment
502
Registered
2017-11-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Acetazolamide: One arm was given Cap Acetazolamide alone (250 mg OD SR) Control Intervention1: Acetazolamide (250 mg SR OD), Dexamethasone (4 mg BD): Participants of Second arm were gi

Sponsors

Director General Armed Forces Medical Services
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthy males with no exposure to high altitude area ( >9000 ft) in last 3 years

Exclusion criteria

Exclusion criteria: Any cardiovascular or respiratory disease History of allergy to sulphonamides

Design outcomes

Primary

MeasureTime frame
Incidence of acute mountain sickness and measurement of exercise capacityTimepoint: Initially at sea-level and again after spending 4 days at high altitude—

Secondary

MeasureTime frame
Measurement of exercise capacityTimepoint: At sea-level and and measurement of exercise capacity—

Countries

India

Contacts

Public ContactDr Gaurav Sikri

Armed Forces Medical services

drgaurav35@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026